囊性纤维化及中国儿童特点

doi:10.3969/j.issn.1006-7795.2016.05.006

首都医科大学学报 ›› 2016, Vol. 37 ›› Issue (5): 588-592.doi: 10.3969/j.issn.1006-7795.2016.05.006

囊性纤维化及中国儿童特点

王昊, 徐保平, 申昆玲

首都医科大学附属北京儿童医院呼吸科国家呼吸系统疾病临床医学研究中心, 北京 100045

收稿日期:2016-06-03 出版日期:2016-10-21 发布日期:2016-10-19
通讯作者: 申昆玲 E-mail:kunlingshen1717@163.com
基金资助:
国家科技支撑计划（2013BAI09B11），首都医科大学基础-临床科研合作基金（重点14JL06）。

Cystic fibrosis and literature review of Chinese pediatric cases

Wang Hao, Xu Baoping, Shen Kunling

Respiratory Department, Beijing Children's Hospital, Capital Medical University;China National Clinical Research Center for Respiratory Diseases, Beijing 100045, China

Received:2016-06-03 Online:2016-10-21 Published:2016-10-19
Supported by:
This study was supported by National Science and Technology Support Program(2013BAI09B11), Clinical research of Capital Medical University(Key Program 14JL06).

摘要/Abstract

摘要： 囊性纤维化是一种以肺部病变伴随其他多系统受累为主要特点的常染色体隐性遗传病，高加索人群发病率较高，但近年来随着对该病认识的提高及基因检测技术的发展，我国对儿童囊性纤维化的诊断有所增加。本文对该病发病机制、诊疗及中国儿童病例特点作一概述。

关键词: 囊性纤维化, 儿童, 中国人

Abstract: Objective Cystic fibrosis (CF) is one of the life-shortening genetic diseases, involving lung and other system. The prevalence of CF in Caucasian is higher than that in Chinese. But the recent years the diagnosis of cystic fibrosis in Chinese has increased. The aim of this review is to elaborate the pathogenesis, diagnosis, treatment and the characteristics of Chinese pediatric cases with CF.

Key words: cystic fibrosis, children, Chinese

中图分类号:

王昊, 徐保平, 申昆玲. 囊性纤维化及中国儿童特点[J]. 首都医科大学学报, 2016, 37(5): 588-592.

Wang Hao, Xu Baoping, Shen Kunling. Cystic fibrosis and literature review of Chinese pediatric cases[J]. Journal of Capital Medical University, 2016, 37(5): 588-592.

参考文献

[1] Davis P B. Cystic fibrosis since 1938[J]. Am J Respir Crit Care Med,2006,173(5):475-482.
[2] Paranjape S M, Mogayzel P J Jr. Cystic fibrosis[J]. Pediatr Rev, 2014, 35(5):194-205.
[3] Colombo C, Littlewood J. The implementation of standards of care in Europe:state of art[J]. J Cyst Fibros, 2011, 10 Suppl 2:S7-S15.
[4] Singh M, Rebordosa C, Bemholz J, et al. Epidemiology and genetics of cystic fibrosis in Asia:In preparation for the next-generation treatments[J]. Respirology, 2015, 20(8):1172-1181.
[5] Yamashiro Y, Shimizu T, Oguchi S, et al. The estimated incidence of cystic fibrosis in Japan[J]. J Pediatr Gastroenterol Nutr, 1997, 24(5):544-547.
[6] Riordan J R, Rommens J M, Kerem B, et al. Identification of the cystic fibrosis gene:cloning and characterization of complementary DNA[J]. Science,1989,245(4922):1066-1073.
[7] CFMD/CFTR1 Team. Cystic fibrosis mutation database[EB/OL].(2011-04-25)[2016-06-01] http://www.genet.sickkids.on.ca/team.html.
[8] Boyle M P, De Boeck K. A new era in the treatment of cystic fibrosis:correction of the underlying CFTR defect[J]. Lancet Respir Med, 2013,1(2):158-163.
[9] Farrell P M, Rosenstein B J, White T B, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults:Cystic Fibrosis Foundation consensus report[J]. J Pediatr, 2008,153(2):S4-S14.
[10] Coakley J, Scott S, Mackay R, et al. Sweat testing for cystic fibrosis:standards of performance in Australasia[J]. Ann Clin Biochem, 2009, 46(Pt4):332-337.
[11] Wagener J S, Zemanick E T, Sontag M K. Newborn screening for cystic fibrosis[J]. Curr Opin Pediatr, 2012,24(3):329-335.
[12] Crossley J R, Elliott R B, Smith P A. Dried-blood spot screening for cystic fibrosis in the newborn[J]. Lancet, 1979,1(8114):472-474.
[13] Watson M S, Cutting G R, Desnick R J, et al. Cystic fibrosis population carrier screening:2004 revision of American College of Medical Genetics mutation panel[J]. Genet Med,2004,6(5):387-391.
[14] Flume P A, Robinson K A, O'Sullivan B P, et, al. Cystic fibrosis pulmonary guidelines:airway clearance therapies[J]. Respir Care, 2009, 54(4):522-537.
[15] Konstan M W, Ratjen F. Effect of dornase alfa on inflammation and lung function:potential role in the early treatment of cystic fibrosis[J]. J Cyst Fibros, 2012, 11(2):78-83.
[16] Treggiari M M, Retsch-Bogart G, Mayer-Hamblett N, et al. Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis[J]. Arch Pediatr Adolesc Med, 2011, 165(9):847-856.
[17] Cai Y, Chai D, Wang R, et al. Effectiveness and safety of macrolides in cystic fibrosis patients:a meta-analysis and systematic review[J]. J Antimicrob Chemother, 2011, 66(5):968-978.
[18] Sermet-Gaudelus I. Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation[J]. Eur Respir Rev,2013,22(127):66-71.
[19] 李楠,何冰,王广发,等. 囊性纤维化一例报告并文献复习[J]. 中华结核和呼吸杂志,2003,26(9):559-562.
[20] 王家伦, 谭郁彬. 囊性纤维化一例尸检报告[J]. 中华病理学杂志, 1983, 12(2):240.
[21] 陈坤华, 徐达, 刘作义. 小儿囊性纤维性变(附7例报告)[J]. 遗传与疾病, 1985, 2(4):257-259.
[22] 张晨美, 曹霞云. 囊性纤维化病2例报告[J]. 临床儿科杂志, 1993, 11(1):48.
[23] Wang M C, Shu S G, Chang S M, et al. Cystic fibrosis in two Chinese infants in Taiwan[J]. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, 1993, 34(4):314-321.
[24] Wang J Y, Hsieh K H, Chang M H, et al. Cystic fibrosis:report of a Chinese case with suggestive family history[J]. Taiwan Yi Xue Huai Za Zhi, 1987, 86(8):897-901.
[25] Wagner J A, Vassilakis A, Yee K, et al. Two novel mutation in a cystic fibrosis patient of Chinese origin[J]. Hum Genet, 1999,104(6):511-515.
[26] Boon W H. Cystic fibrosis in a Chinese girl[J]. J Singapore Paediatr Soc, 1975, 17(2):96-102.
[27] Crawford J, Labrinidis A, Garey W F, et al. A splincing mutation (1898+5G→T) in the CFTR gene causing cystic fibrosis[J]. Hum Mutant, 1995,5(1):101-102.
[28] Zielenski J, Markiewicz D, Lin S P, et al. Skipping of exon 12 as a consequence of a point mutation (1898+5G→T) in the cystic fibrosis transmembrane conductance regulator gene found in a consanguineous Chinese family[J]. Clin Genet, 1995, 47(3):125-132.
[29] Wu C L, Shu S G, Zielenski J, et al. Novel cystic fibrosis mutation (2215insG) in two adolescent Taiwanese siblings[J]. J Formos Med Assoc, 2000, 99(7):564-567.
[30] Alper O M, Shu S G, Lee M H, et al. Detection of Novel CFTR mutations in Taiwanese cystic fibrosis patients[J]. J Formos Med Assoc, 2003, 102(5):287-291.
[31] Chen H J, Lin S P, Lee H C, et al. Cystic fibrosis with homozygous R553X mutation in a Taiwanese child[J]. J Hum Genet, 2005, 50(12):674-678.
[32] 王犇, 杨丽. 囊性纤维化累及多系统一例[J]. 华西医学, 2012, 27(6):852-854.
[33] 刘金荣, 彭芸, 赵宇红,等. 中国儿童囊性纤维化二例临床特点及基因分析[J] 中华儿科杂志, 2012,50(11):829-833.
[34] Cheng Y, Ning G, Song B, et al. A Chinese girl with cystic fibrosis:a case report identified by sweat and genetic tests[J]. Chin Med J (Engl), 2012, 125(4):719.
[35] Xie Y, Huang X, Liang Y, et al. A new compound heterozygous CFTR mutation in a Chinese family with cystic fibrosis[J]. Clin Respir J, 2015,[Epub ahead of print].
[36] Liu Y, Wang L, Tian X, et al. Characterization of gene mutation and phenotypes of cystic fibrosis in Chinese patients[J]. Respirology, 2015, 20(2):312-318.
[37] 陈柏华, 张思仲, 杨元. 我国大陆首例DNA分析证实的囊性纤维化病及其突变分析[J]. 中华医学遗传学杂志, 1995,12(1):5-9.
[38] Li N, Pei P, Bu D F, et al. A novel CFTR mutation found in a Chinese patient with cystic fibrosis[J]. Chin Med J (Engl), 2006, 119(2):103-109.

囊性纤维化及中国儿童特点

Cystic fibrosis and literature review of Chinese pediatric cases

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李昂, 皇惠杰, 杨世青, 侯晓玲, 向莉. 长程治疗管理哮喘儿童的肺功能轨迹特征分析[J]. 首都医科大学学报, 2022, 43(6): 940-947.
[2]	吴鸿波, 李曼曼, 林丽丽, 李丽华. 单中心儿科门急诊0~16岁儿童10年死亡数据分析[J]. 首都医科大学学报, 2021, 42(5): 852-856.
[3]	马佳佳, 岳红丽, 王德祥, 金旭, 韩如泉. 不同剂量右美托咪定对儿童颅脑术后苏醒期躁动的影响[J]. 首都医科大学学报, 2021, 42(3): 459-463.
[4]	王振民, 宫剑. 儿童开颅术后脑脊液外引流与颅内感染的相关性研究[J]. 首都医科大学学报, 2021, 42(2): 269-272.
[5]	段超, 王生才, 金眉, 张大伟, 赵文, 王希思, 赵倩, 邰隽, 张杰, 何乐建, 张建国, 倪鑫, 马晓莉. 儿童头颈部非横纹肌肉瘤软组织肉瘤临床研究[J]. 首都医科大学学报, 2019, 40(6): 921-926.
[6]	贾晨光, 周翾, 王彬, 朱光华, 秦茂权. 异基因造血干细胞移植治疗儿童急性髓系白血病的临床观察[J]. 首都医科大学学报, 2019, 40(2): 163-168.
[7]	王希思, 杨维, 黄程, 赵文, 赵倩, 段超, 苏雁, 金眉, 张大伟, 秦红, 王焕民, 马晓莉. 儿童肝母细胞瘤的临床特征和治疗效果评价[J]. 首都医科大学学报, 2019, 40(2): 169-173.
[8]	张利强, 陈振萍, 郑杰, 马洁, 吴润晖. 国产甲磺酸伊马替尼治疗儿童慢性髓系白血病慢性期的早期疗效和安全性分析[J]. 首都医科大学学报, 2019, 40(2): 174-178.
[9]	张金, 任思其, 李舒婷, 李苗, 龚小军, 孙艳玲, 武万水, 孙黎明, 杜淑旭. 脑脊液肿瘤坏死因子-α和干扰素-γ对髓母细胞瘤患儿的预后评价分析[J]. 首都医科大学学报, 2019, 40(2): 201-204.
[10]	张利强, 郑杰, 马洁, 陈振萍, 吴润晖. 9例具有致病基因变异的儿童期原发性血小板增多症临床分析[J]. 首都医科大学学报, 2018, 39(4): 607-611.
[11]	李莹, 祁森荣, 华琳, 尚佳健. 儿童复发性腮腺炎患者与正常儿童腮腺液微生物群落多样性的差异[J]. 首都医科大学学报, 2018, 39(3): 453-457.
[12]	李文风, 文宏伟, 刘玥, 彭芸, 程华, 李宏彬, 邰隽. 弥散峰度成像对儿童阻塞性睡眠呼吸暂停综合征脑微结构变化的研究[J]. 首都医科大学学报, 2018, 39(2): 178-184.
[13]	皇惠杰, 刘晓颖, 侯晓玲, 苗青, 向莉. 尘螨变应原免疫治疗联合药物治疗对哮喘合并变应性鼻炎患儿临床疗效及气道高反应性的影响[J]. 首都医科大学学报, 2016, 37(5): 568-573.
[14]	王生才, 关乐静, 张杰, 倪鑫, 张亚梅, 刘原虎, 葛文彤, 李晓丹, 邰隽. 儿童头颈部脂肪母细胞瘤临床分析[J]. 首都医科大学学报, 2016, 37(2): 120-124.
[15]	方伯梁, 钱素云. PICU脓毒症及严重脓毒症患儿肠内营养摄入能量及蛋白质充分性及其与预后的关系[J]. 首都医科大学学报, 2016, 37(2): 125-129.